TEERIN LIEWLUCK, MD AWARDED THE SCIENTIFIC IMPACT AWARD FROM AANEM

Teerin Liewluck, MD, has been chosen as one of the winners of AANEM’s 2021 Scientific Impact Award. Dr. Liewluck was the senior author on a published paper titled, Neuromuscular Transmission Defects in Myopathies: Rare but Worth Searching For.

Researchers Discover Test to Predict Which Patients with Rare Blood Disease Will Respond to Only FDA-Approved Treatment, and Identify Alternative Therapy

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

O-REU Program

Recently, the Texas A&M University College of Engineering kicked off an online version of its Research Experiences for Undergraduates program. Taking place over the summer, this fully remote program gives 58 students from around the U.S. valuable research experience in computational modeling, theory and data-driven topics in science and engineering.